Beijing’s Bohui Innovation Co. commercializes PCR-based diagnostic system for rapid detection of influenza A and B-type DNA

With a probe taken from pharyngeal swabs, either virus DNAS can be detected qualitatively. The product was developed by the company’s Guangzhou subsidiary Bohui Biotechnology Development Ltd.

China Bio news release, October 25, 2013

Beijing’s Bohui Innovation Co. commercializes PCR-based diagnostic system for rapid detection of influenza A and B-type DNA
Scroll to top